Tesamorelin supports research involving metabolic regulation, growth factor signaling, adipose tissue modeling, and endocrine system function, making it a valuable peptide in regenerative and metabolic-focused experimental systems.
Growth Hormone–Releasing Hormone (GHRH) Analog / IGF-1 Pathway Modulator / Metabolic Research Peptide
Tesamorelin is a synthetic 44–amino acid peptide analog of endogenous growth hormone–releasing hormone (GHRH).
It is widely studied for its potent ability to stimulate growth hormone (GH) secretion, elevate IGF-1 production, and influence lipid metabolism and cellular repair processes.
Tesamorelin supports research involving metabolic regulation, growth factor signaling, adipose tissue modeling, and endocrine system function, making it a valuable peptide in regenerative and metabolic-focused experimental systems.
RESEARCH
Tesamorelin is a laboratory-engineered analog of native human GHRH, modified to enhance stability and receptor affinity while preserving physiological signaling characteristics.
It has been extensively studied for its ability to activate GHRH receptors on pituitary somatotroph cells, resulting in increased pulsatile secretion of growth hormone and subsequent induction of IGF-1 pathways.
Tesamorelin is supplied as a lyophilized powder for controlled laboratory experimentation and is intended exclusively for in vitro research studies focusing on growth factor modulation, metabolism, and endocrine signaling.
Chemical Information:
Molecular Formula: C211H366N72O58S
Molecular Weight: 5135.8 g/mol
Sequence: Modified human GHRH(1–44) analog
Structure: Linear 44–amino acid peptide with enhanced stability
Description:
Tesamorelin is a synthetic peptide analog provided exclusively for qualified laboratory research.
This compound is intended solely for non-clinical in vitro experimental studies under controlled laboratory conditions.
Presented in lyophilized powder form, Tesamorelin is suitable for biochemical analysis, endocrine receptor studies, metabolic research, and growth factor pathway modeling.
No claims regarding biological activity, therapeutic utility, or clinical outcomes are made or implied.
Research Applications:
Growth Hormone Secretion Studies
Investigate Tesamorelin’s ability to activate pituitary GHRH receptors and modulate GH pulse amplitude and frequency.
IGF-1 Pathway Modeling
Assess downstream effects on insulin-like growth factor signaling related to tissue repair, growth, and metabolic activity.
Lipid Metabolism Research
Examine its influence on adipocyte function, lipolysis, and fat redistribution in metabolic pathway studies.
Endocrine System Regulation
Explore interactions among hypothalamic–pituitary axis components and feedback loop dynamics.
Cellular Growth & Regeneration Studies
Evaluate impacts on protein synthesis, cellular rejuvenation, and recovery modeling in tissue research systems.
Storage and Handling:
Product Specifications:
Purity: ≥99% (HPLC Certified)
Appearance: Lyophilized white powder
Solubility: Soluble in bacteriostatic water
Form: 10 mg vial
Compliance Notice:
Tesamorelin is FOR RESEARCH USE ONLY.
It is not intended for human or veterinary use.
This compound has not been evaluated by the FDA.
Improper use may violate federal, state, or local laws.
By purchasing this material, the buyer acknowledges it is for controlled in vitro research purposes only.
Key Research Features:
Mechanism of Action (Simplified):
Applications / Possible Uses:
Form / Notes: